Vial
PrivateLast Round
Debt
May 28, 2025
Total Funding Raised
$134M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vial operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series B round in November 2022.
Vial is a next-generation pharmaceutical company that operates a tech-enabled clinical research organization (CRO) and develops computationally designed therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vial Comparables
Compare Vial with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lindus Health | 89% | |
| Curebase | 84% | |
| Paradigm Health | 81% |
For institutional investors. Book with your work email.
Vial Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 28, 2025 | ||||
| Series B | Nov 30, 2022 | ||||
| Series A | Nov 1, 2022 | ||||
| Seed | Apr 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Vial Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| Byers Capital | Series A, Series B |
| Buckley Ventures | Series A, Seed |
| General Catalyst | Series A, Series B |
| BoxGroup | Series A, Series B |
| Base10 Partners | Series A |
| ATEL Ventures | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Developing an IL-13 x TSLP bispecific antibody for respiratory indications.
- Apr 1, 2026
Grown rapidly to a team of 100+ employees since October 2020.
For institutional investors. Book with your work email.
Vial Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vial's valuation, stock price, and market status.
Is Vial a public or private company?
Vial is a private company.
What is the current stock price of Vial?
Vial is a private company, so its shares have no public market price. Caplight tracks Vial's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vial worth (valuation)?
Valuation information for Vial is not publicly available.
Can I buy Vial stock?
Vial shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vial's last funding round?
Vial's most recent funding round was Debt on May 28, 2025.
Who are the main investors in Vial?
Key investors in Vial include Buckley Ventures, General Catalyst, ATEL Ventures.
Will Vial IPO soon?
No public IPO plans have been announced for Vial.
How can I track Vial secondary market activity?
Caplight tracks bids, offers, and trades in Vial's shares on secondary markets.